These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 15581995
1. Management of upper gastrointestinal obstruction in advanced ovarian cancer with intraluminal stents. Rao A, Land R, Carter J. Gynecol Oncol; 2004 Dec; 95(3):739-41. PubMed ID: 15581995 [Abstract] [Full Text] [Related]
2. Management of large bowel obstruction in advanced ovarian cancer with intraluminal stents. Carter J, Valmadre S, Dalrymple C, Atkinson K, Young C. Gynecol Oncol; 2002 Jan; 84(1):176-9. PubMed ID: 11748998 [Abstract] [Full Text] [Related]
3. Placement of two overlapping uncovered metallic stents for malignant gastric outlet and duodenal obstruction due to colon cancer. Zippi M, Traversa G, Masini A, De Felici I, Febbraro I, Mattei E, Pica R, Bertoldi I, Occhigrossi G. Dig Liver Dis; 2006 Aug; 38(8):612-4. PubMed ID: 16828352 [Abstract] [Full Text] [Related]
5. Combined arterial infusion and stent implantation compared with metal stent alone in treatment of malignant gastroduodenal obstruction. Wang Z, Chen K, Gong J, Zheng Y, Wang T. Cardiovasc Intervent Radiol; 2009 Sep; 32(5):1011-8. PubMed ID: 19669831 [Abstract] [Full Text] [Related]
7. The use of colorectal stents for palliation of large-bowel obstruction due to recurrent gynecologic cancer. Pothuri B, Guirguis A, Gerdes H, Barakat RR, Chi DS. Gynecol Oncol; 2004 Dec; 95(3):513-7. PubMed ID: 15581955 [Abstract] [Full Text] [Related]
17. [Clinical outcome of the use of self-expandable metallic stents (SEMS) for palliation of patients with malignant upper GI obstruction caused by incurable gastric cancer]. Fujitani K, Satomi E, Takeno A, Hirao M, Tsujinaka T, Nakamori S, Mishima H, Ikenaga M, Kashiwazaki M, Ikeda M. Gan To Kagaku Ryoho; 2005 Oct; 32(11):1623-6. PubMed ID: 16315889 [Abstract] [Full Text] [Related]
18. Antral localization worsens the efficacy of enteral stents in malignant digestive tumors. Dolz C, Vilella À, González Carro P, González Huix F, Espinós JC, Santolaria S, Pérez Roldán F, Figa M, Loras C, Andreu H. Gastroenterol Hepatol; 2011 Feb; 34(2):63-8. PubMed ID: 21353341 [Abstract] [Full Text] [Related]
19. A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer. Chi DS, Phaëton R, Miner TJ, Kardos SV, Diaz JP, Leitao MM, Gardner G, Huh J, Tew WP, Konner JA, Sonoda Y, Abu-Rustum NR, Barakat RR, Jaques DP. Oncologist; 2009 Aug; 14(8):835-9. PubMed ID: 19684071 [Abstract] [Full Text] [Related]